Tianjin Pharmaceutical Da Ren Tang Group (SHSE:600329) Change In Inventory : ¥0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Tianjin Pharmaceutical Da Ren Tang Group Change In Inventory?

Tianjin Pharmaceutical Da Ren Tang Group's change in inventory for the quarter that ended in Mar. 2024 was ¥0 Mil. It means Tianjin Pharmaceutical Da Ren Tang Group's inventory stayed the same from Dec. 2023 to Mar. 2024 .

Tianjin Pharmaceutical Da Ren Tang Group's change in inventory for the fiscal year that ended in Dec. 2023 was ¥-165 Mil. It means Tianjin Pharmaceutical Da Ren Tang Group's inventory increased by ¥165 Mil from Dec. 2022 to Dec. 2023 .

Tianjin Pharmaceutical Da Ren Tang Group's Total Inventories for the quarter that ended in Mar. 2024 was ¥1,483 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Tianjin Pharmaceutical Da Ren Tang Group's Days Inventory for the quarter that ended in Mar. 2024 was 137.69.

Inventory Turnover measures how fast the company turns over its inventory within a year. Tianjin Pharmaceutical Da Ren Tang Group's Inventory Turnover for the quarter that ended in Mar. 2024 was 0.66.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Tianjin Pharmaceutical Da Ren Tang Group's Inventory-to-Revenue for the quarter that ended in Mar. 2024 was 0.73.

Tianjin Pharmaceutical Da Ren Tang Group Change In Inventory Historical Data

The historical data trend for Tianjin Pharmaceutical Da Ren Tang Group's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tianjin Pharmaceutical Da Ren Tang Group Change In Inventory Chart

Tianjin Pharmaceutical Da Ren Tang Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Inventory

Get a 7-Day Free Trial

-292.57

110.96

-47.40

58.87

-165.34

Tianjin Pharmaceutical Da Ren Tang Group Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Inventory	Get a 7-Day Free Trial															-	-	-	-	-

Tianjin Pharmaceutical Da Ren Tang Group Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

Tianjin Pharmaceutical Da Ren Tang Group (SHSE:600329) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Tianjin Pharmaceutical Da Ren Tang Group's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	1524.941	/	1010.616	*	365 / 4
	=	137.69

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Tianjin Pharmaceutical Da Ren Tang Group's Inventory Turnover for the quarter that ended in Mar. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	1010.616	/	1524.941
	=	0.66

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Tianjin Pharmaceutical Da Ren Tang Group's Inventory to Revenue for the quarter that ended in Mar. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	1524.941	/	2085.588
	=	0.73

Tianjin Pharmaceutical Da Ren Tang Group Change In Inventory Related Terms

Thank you for viewing the detailed overview of Tianjin Pharmaceutical Da Ren Tang Group's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Tianjin Pharmaceutical Da Ren Tang Group (SHSE:600329) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd (SHSE:600329) » Definitions » Change In Inventory

Traded in Other Exchanges

T14:Singapore

Address

No. 17 Baidi Road, Zhong Xin Mansion, Nankai District, Tianjin, CHN, 300193

Website

http://www.jydrt.com.cn

Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd is a pharmaceutical manufacturing company. The company manufactures and sells traditional Chinese medicine, western medicine, and healthcare products in the People's Republic of China. It operates in two segments namely The Chinese Medicine segment and The Western Medicine segment. The Chinese Medicine segment manufactures Chinese pharmaceutical products under brands owned by the group. The Western Medicine segment manufactures western pharmaceutical products through cooperation with foreign companies. The company earns the majority of its revenue from the sale of Chinese pharmaceutical products.

Tianjin Pharmaceutical Da Ren Tang Group (SHSE:600329) Headlines

No Headlines